S&P Global Ratings reports that India, South Korea, and Thailand are most at risk of facing higher US tariffs under the Trump ...

Zydus Lifesciences: The company and its subsidiaries received final approval from the United States Food and Drug Administration (US FDA) to manufacture Ibuprofen and Famotidine tablets, 800 mg/26.6 ...

The Indian stock market has seen a dramatic downturn in 2025, with major indices losing substantial value. Investors are ...

India's equity benchmark indices Sensex and Nifty experienced a significant drop in their early trade on Monday (24 February) ...

IST, the barometer index, the S&P BSE Sensex, tumbled 787.96 points or 1.05% to 74,523.66. The Nifty 50 index dropped 235.40 points or 1.03% to 22,560.50.

India and Japan have a unique opportunity to gain from US tariffs, says Hero Enterprises' Sunil Kant Munjal. He believes ...

The India-US ties will depend on India's readiness to be a willing partner in the American designs on China and what it will ...

Gold Rate Today in India: Gold price shone on Monday morning, February 24, with a sharp surge around Rs 100. The yellow metal ...

The S&P BSE Sensex lost 676.83 points to 74,634.23, while the NSE Nifty50 fell 203.05 points to 22,592.85 as of 10 AM. IT ...

Indian indices Sensex and Nifty opened lower, mirroring global market downturn fueled by US inflation concerns and FII ...

Out of the 30 Sensex shares, 28 were in red with Zomato, HCL Tech, PowerGrid, HDFC Bank, and IndusInd Bank being the biggest losers falling up to 2 per cent.